K18- and cag-hace2 transgenic mouse models and sars-cov-2: implications for neurodegeneration research

HIGHLIGHTS

  • who: Simona Dedoni et al. from the Department of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, Department of Neuroscience, Georgetown University Medical Center, Washington, DC, USA have published the article: K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research, in the Journal: Molecules 2022, 4142 of /2022/
  • what: The aim of this review is to summarize the existing information regarding COVID-19-related neuropathology in K18- and CAG-hACE2 mouse models. The aim of this study was therefore to demonstrate the efficacy of EK1 and EK1C4 peptides in_vivo . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?